Roboz GJ, Pabst T, Aribi A, Brandwein JM, Döhner H, Fiedler W, Riether C, Gandini D, Geddes M, Hou J-Z, Yee K, Hultberg A, Huselton E, Jacobs J, Zabrocki P, Lech-Marańda E, Louwers M, Nottage K, Platzbecker U, Rampal R, Salman M, Shah P, Wilson K, Stuart M, Subklewe M, Sumbul A, Wang ES, Wierzbowska A, Yao B, Patel R, George A, Islam N, Smith C, Boyiadzis M, Borthakur G. Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study. Haematologica; https://doi.org/10.3324/haematol.2026.300917 [Early view].